AAF
UTHR icon

Andra AP-fonden’s United Therapeutics UTHR Stock Holding History

Andra AP-fonden’s Portfolio UTHR Stock Details UTHR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$15.5M Sell
26,144
-3,456
-12% -$1.72M 0.18% 132
2025
Q4 		$14.4M Sell
29,600
-44,200
-60% -$20.6M 0.18% 165
2025
Q3 		$30.9M Sell
73,800
-44,600
-38% -$15M 0.4% 80
2025
Q2 		$34M Buy
118,400
+16,300
+16% +$4.87M 0.47% 61
2025
Q1 		$31.5M Buy
102,100
+35,500
+53% +$12.2M 0.52% 45
2024
Q4 		$23.5M Buy
66,600
+5,500
+9% +$2.02M 0.38% 84
2024
Q3 		$21.9M Buy
61,100
+26,000
+74% +$8.78M 0.32% 100
2024
Q2 		$11.2M Buy
35,100
+1,900
+6% +$503K 0.19% 175
2024
Q1 		$7.63M Sell
33,200
-2,300
-6% -$519K 0.14% 227
2023
Q4 		$7.81M Buy
35,500
+1,100
+3% +$254K 0.41% 108
2023
Q3 		$7.77M Sell
34,400
-900
-3% -$207K 0.46% 83
2023
Q2 		$7.79M Buy
+35,300
New +$7.82M 0.2% 204
2019
Q2 		– Sell
-54,100
Closed -$6.35M – 680
2019
Q1 		$6.35M Buy
+54,100
New +$6.3M 0.18% 205
2018
Q3 		$8.79M Sell
68,700
-8,000
-10% -$990K 0.23% 119
2018
Q2 		$8.68M Buy
76,700
+5,900
+8% +$649K 0.23% 92
2018
Q1 		$7.96M Buy
70,800
+58,200
+462% +$7.39M 0.21% 135
2017
Q4 		$1.86M Sell
12,600
-3,100
-20% -$394K 0.04% 584
2017
Q3 		$1.84M Sell
15,700
-11,200
-42% -$1.43M 0.04% 565
2017
Q2 		$3.49M Sell
26,900
-10,000
-27% -$1.25M 0.09% 373
2017
Q1 		$5M Buy
36,900
+14,200
+63% +$2.15M 0.12% 239
2016
Q4 		$3.26M Sell
22,700
-2,300
-9% -$294K 0.09% 368
2016
Q3 		$2.95M Sell
25,000
-6,300
-20% -$757K 0.08% 395
2016
Q2 		$3.31M Buy
31,300
+9,700
+45% +$1.08M 0.08% 361
2016
Q1 		$2.41M Buy
21,600
+7,800
+57% +$987K 0.06% 479
2015
Q4 		$2.16M Sell
13,800
-6,400
-32% -$932K 0.06% 459
2015
Q3 		$2.65M Sell
20,200
-1,600
-7% -$257K 0.08% 398
2015
Q2 		$3.79M Buy
+21,800
New +$3.92M 0.11% 294

Other funds holding UTHR

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return

Andra AP-fonden's UTHR Position: Q1 2026 in Review

Andra AP-fonden reduced its United Therapeutics (UTHR) stake by 12% in Q1 2026, selling an estimated $1.72M and leaving 26,144 shares worth $15.5M. The position accounts for 0.18% of the portfolio, ranked #132.

Andra AP-fonden first reported a position in UTHR in Q2 2015 and has held it in 27 quarters since. The position peaked at $34M in Q2 2025. 854 funds tracked by Wall St. Rank hold UTHR as of Q1 2026.

  • Andra AP-fonden held 26,144 shares of United Therapeutics worth $15.5M as of Q1 2026.
  • Andra AP-fonden sold 3,456 United Therapeutics shares in Q1 2026, an estimated $1.72M.
  • United Therapeutics made up 0.18% of Andra AP-fonden's portfolio in Q1 2026, its #132 holding.
  • Andra AP-fonden first reported a position in United Therapeutics in Q2 2015 and has held it in 27 quarters since.
  • Andra AP-fonden's United Therapeutics position peaked at $34M in Q2 2025.
  • 854 funds tracked by Wall St. Rank held United Therapeutics as of Q1 2026.

Based on Andra AP-fonden's 13F filing for Q1 2026, filed 8 May 2026.